Stereotactic body radiotherapy as a boost after external beam radiotherapy for high-risk prostate cancer patients

Conclusions: SBRT boost treatment after pelvic irradiation has been used with a good biochemical control and acceptable toxicity in high-risk prostate cancer patients. More extensive randomized trial results are needed on the subject.
Source: Indian Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research